S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

IVERIC bio Earnings Date, Estimates & Call Transcripts (2022)

-0.22 (-2.29%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.55 million shs
Average Volume
1.75 million shs
Market Capitalization
$1.09 billion
P/E Ratio
Dividend Yield
Price Target

Earnings Summary

Earnings Date
Aug. 3Estimated
Actual EPS
(May. 4)
Consensus EPS
(May. 4)
Last Year's Q2 EPS
Skip Charts & View Estimated and Actual Earnings Data

ISEE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ISEE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IVERIC bio Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.29)($0.29)($0.29)
Q2 20223($0.34)($0.24)($0.30)
Q3 20223($0.42)$0.39($0.09)
Q4 20223($0.46)($0.24)($0.37)
FY 202210($1.51)($0.38)($1.05)

ISEE Earnings Date and Information

IVERIC bio last released its quarterly earnings data on May 4th, 2022. The reported ($0.29) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.29). IVERIC bio has generated ($1.13) earnings per share over the last year (($1.13) diluted earnings per share). Earnings for IVERIC bio are expected to decrease in the coming year, from ($1.27) to ($1.35) per share. IVERIC bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based off prior year's report dates.

IVERIC bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/4/2022Q1 2022($0.29)($0.29)($0.29)    
2/24/2022Q4 2021($0.24)($0.29)($0.05)($0.29)    
2/27/2020Q4 2019($0.28)($0.39)($0.11)($0.39)  
11/12/2019Q3 2019($0.35)($0.35)($0.35)  
8/1/2019Q2 2019($0.35)($0.35)($0.35)
2/26/2019Q4 2018($0.37)($0.53)($0.16)($3.68)
10/31/2018Q3 2018($0.43)($0.41)+$0.02($0.41)
8/1/2018Q2 2018($0.40)($0.37)+$0.03($0.37)
5/9/2018Q1 2018($0.36)($0.36)($0.36)
2/27/2018Q4 2017($0.58)($0.26)+$0.32($0.26)
11/8/2017Q3 2017$4.38$5.25+$0.87$5.25$185.00 million$206.65 million
7/26/2017Q2 2017($1.07)($0.62)+$0.45($0.62)$1.44 million$1.66 million
5/3/2017Q1 2017($1.31)($1.20)+$0.11($1.20)$1.94 million$1.66 million
2/28/2017Q4 2016($1.64)($1.86)($0.22)($1.86)$6.27 million$5.32 million
11/8/2016Q3 2016($1.60)($1.71)($0.11)($1.71)$6.77 million$1.67 million
8/3/2016Q2 2016($0.91)($0.85)+$0.06($0.85)$24.14 million$28.20 million
5/4/2016Q1 2016($1.32)($1.03)+$0.29($1.03)$3.89 million$15.72 million
2/24/2016Q4 2015($1.36)($1.02)+$0.34($1.02)$4.05 million$4.78 million
11/5/2015Q3 2015($0.98)($1.14)($0.16)($1.14)$12.96 million$3.45 million
8/5/2015Q2 2015($0.98)($1.08)($0.10)($1.08)$1.98 million$1.60 million
5/11/2015Q1 2015($0.99)$0.22+$1.21$0.22$4.35 million$41.68 million
2/23/2015Q4 2014($0.41)($1.06)($0.65)($1.06)$20.35 million$1.68 million
11/11/2014Q3 2014($0.46)$0.31+$0.77$0.31$40.10 million$39.58 million
8/6/2014Q2 2014($0.58)($1.57)($0.99)($1.57)
5/13/2014Q1 2014($0.67)($0.64)+$0.03($0.64)
2/27/2014Q4 2013($0.50)($0.65)($0.15)($0.65)
11/13/2013Q3 2013($1.67)($10.26)($8.59)($10.26)

IVERIC bio Earnings - Frequently Asked Questions

When is IVERIC bio's earnings date?

IVERIC bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 3rd, 2022 based off last year's report dates. Learn more on ISEE's earnings history.

Did IVERIC bio beat their earnings estimates last quarter?

In the previous quarter, IVERIC bio (NASDAQ:ISEE) reported ($0.29) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.29). Learn more on analysts' earnings estimate vs. ISEE's actual earnings.

How can I listen to IVERIC bio's earnings conference call?

The conference call for IVERIC bio's latest earnings report can be listened to online. Listen to Conference Call

How can I read IVERIC bio's conference call transcript?

The conference call transcript for IVERIC bio's latest earnings report can be read online. Read Transcript

How much profit does IVERIC bio generate each year?

IVERIC bio (NASDAQ:ISEE) has a recorded net income of -$114.52 million. ISEE has generated -$1.13 earnings per share over the last four quarters.

What is IVERIC bio's EPS forecast for next year?

IVERIC bio's earnings are expected to decrease from ($1.27) per share to ($1.35) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ISEE) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.